共 50 条
- [41] FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model that responds to the FLT3 inhibitor PKC412.BLOOD, 2003, 102 (11) : 107A - 107AGilliland, DGLee, BHWilliams, IRBoulton, CLAnastasiadou, EWojiski, SAmaral, SMCurley, DPDuclos, NHuntly, BGriffin, JD
- [42] FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid diseaseNature, 2020, 584 : 619 - 623Saedis SaevarsdottirThorunn A. OlafsdottirErna V. IvarsdottirGisli H. HalldorssonKristbjorg GunnarsdottirAsgeir SigurdssonAri JohannessonJon K. SigurdssonThorhildur JuliusdottirSigrun H. LundAsgeir O. ArnthorssonEdda L. StyrmisdottirJulius GudmundssonGerdur M. GrondalKristjan SteinssonLars AlfredssonJohan AsklingRafn BenediktssonRagnar BjarnasonArni J. GeirssonBjorn GudbjornssonHallgrimur GudjonssonHaukur HjaltasonAstradur B. HreidarssonLars KlareskogIngrid KockumHelga KristjansdottirThorvardur J. LoveBjorn R. LudvikssonTomas OlssonPall T. OnundarsonKjartan B. OrvarLeonid PadyukovBardur SigurgeirssonVinicius TraganteKristbjorg BjarnadottirThorunn RafnarGisli MassonPatrick SulemDaniel F. GudbjartssonPall MelstedGudmar ThorleifssonGudmundur L. NorddahlUnnur ThorsteinsdottirIngileif JonsdottirKari Stefansson
- [43] The irreversible FLT3 inhibitor FF-10101 is active against a diversity of FLT3 inhibitor resistance mechanismsCANCER RESEARCH, 2022, 82 (12)Ferng, Timothy T.Terada, DaisukeAndo, MakotoTarver, Theodore C.Chaudhary, FihrLin, Kimberly C.Logan, Aaron C.Smith, Catherine C.
- [44] FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid diseaseNATURE, 2020, 584 (7822) : 619 - +Saevarsdottir, SaedisOlafsdottir, Thorunn A.Ivarsdottir, Erna V.Halldorsson, Gisli H.Gunnarsdottir, KristbjorgSigurdsson, AsgeirJohannesson, AriSigurdsson, Jon K.Juliusdottir, ThorhildurLund, Sigrun H.Arnthorsson, Asgeir O.Styrmisdottir, Edda L.Gudmundsson, JuliusGrondal, Gerdur M.Steinsson, KristjanAlfredsson, LarsAskling, JohanBenediktsson, RafnBjarnason, RagnarGeirsson, Arni J.Gudbjornsson, BjornGudjonsson, HallgrimurHjaltason, HaukurHreidarsson, Astradur B.Klareskog, LarsKockum, IngridKristjansdottir, HelgaLove, Thorvardur J.Ludviksson, Bjorn R.Olsson, TomasOnundarson, Pall T.Orvar, Kjartan B.Padyukov, LeonidSigurgeirsson, BardurTragante, ViniciusBjarnadottir, KristbjorgRafnar, ThorunnMasson, GisliSulem, PatrickGudbjartsson, Daniel F.Melsted, PallThorleifsson, GudmarNorddahl, Gudmundur L.Thorsteinsdottir, UnnurJonsdottir, IngileifStefansson, Kari
- [45] Signatures of Disease and Resistance: FLT3 in ReviewJOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S29 - S30Grubbs, C.Ma, C.Ulrich, M.Allen, D.Cronin, N.Escalada, S.Godsey, J.Gonong, B.Hochstein, P.Le, A.Nguyen, T.Racke, F.Utulo, S.Van Ness, M.
- [46] Implications of FLT3 Mutations in the Therapy of Acute Myeloid LeukemiaREVIEWS ON RECENT CLINICAL TRIALS, 2007, 2 (02) : 135 - 141Mattison, Ryan J.Ostler, Kelly R.Locke, Frederick L.Godley, Lucy A.
- [47] Rapid and quantitative detection of mutations of the FLT3 gene in AMLBRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 68 - 69Walsh, VGilkes, AFSweeney, MAustin, SJGale, REMills, KI
- [48] FLT3 inhibitors for the treatment of autoimmune diseaseEXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (11) : 1685 - 1692Whartenby, Katharine A.Small, DonaldCalabresi, Peter A.
- [49] Absence of FLT3 mutations in 181 healthy blood donorsBLOOD, 2007, 110 (11) : 136B - 136BHopkins, Courtney K.Riley, ChristianPepkowitz, SamuelLopategui, Jean
- [50] HM43239, a novel FLT3 inhibitor, has the potential to inhibit mutations resistant to FLT3 inhibitors.CANCER RESEARCH, 2021, 81 (13)Bae, InhwanChoi, JaeyulSong, JiyoungByun, Joo-YunLee, EunyoungSong, TaehunKim, Yu-YonBak, YesolKim, Young HoonAhn, Young GilSuh, Kwee Hyun